Overview
The Nucleic Acid Therapeutics Initiative (NATi)'s annual symposium returns this year with RNA Medicines: From Code to Impact. The conference focuses on how advancements in RNA and oligonucleotide science can be translated into meaningful therapeutic benefit. Bringing together experts across discovery, platform development, and translation, the symposium will explore scientific breakthroughs, enabling capabilities, and collaborative pathways that accelerate the journey from sequence design to real‑world patient impact.
Schedule
Date: 19 May 2026, Tuesday
Time: 9:00 AM - 5:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: Matrix Auditorium Level 2, 30 Biopolis Street, Singapore 138671, 138671
Speakers
Moderator's Profile:
Dr Mohamed ElSayed, Executive Director, NATi, NATi
Dr. Mohamed ElSayed serves as the Executive Director of the Nucleic Acid Therapeutics Initiative (NATi), Singapore’s national platform dedicated to positioning the country as a regional hub and model of excellence in nucleic acid therapeutics research, clinical translation, and commercialisation.
